Integrating Multimodal MRI Habitat and Transformer‐Based Pathomics to Predict High‐Risk Molecular Subtypes and Explore Biological Mechanisms in Adult Diffuse Gliomas
BACKGROUND: This study aims to achieve accurate prediction of high-risk molecular subtypes of gliomas through a cross-scale Combined model, matching the model's classification metrics with patient risk stratification and exploring the underlying biological mechanisms. METHODS: This study retrospectively collected preoperative MRI, postoperative whole-slide pathological images, molecular markers, and clinical data from 456 adult diffuse glioma patients. We separately constructed an MRI habitat prediction model, a WSI Transformer-based deep learning pathomics (PDL) model, and a Combined model. A dynamic nomogram web page for predicting high-risk molecular subtypes was developed based on the Combined model. Patients were stratified into risk groups according to the output scores of the Combined model, and Kaplan-Meier survival analysis and the Log-rank test were employed to evaluate survival differences between the groups. Additionally, differential expression and GO/KEGG enrichment analyses were further performed in the test set with available RNA-seq data to explore transcriptional features and biological processes associated with model-based risk stratification. RESULTS: The Combined model demonstrated the highest AUC (Training set: 0.888, Test set: 0.836) compared to the Habitat model (Training set: 0.832, Test set: 0.798) and the PDL model (Training set: 0.852, Test set: 0.821). The high-risk and low-risk groups, stratified based on the cutoff value derived from the Combined model output scores, exhibited significant survival differences. Exploratory transcriptomic analysis showed that differentially expressed genes between the high- and low-risk groups were mainly enriched in biological processes and pathways related to the extracellular matrix and cell-matrix interactions. CONCLUSION: The cross-scale Combined model not only enabled identification of high-risk molecular subtypes and risk stratification but also showed associations with biologically relevant transcriptional features.
Authors
- Yan Qin Tan (ORCID: https://orcid.org/0000-0002-7529-9807)
- X. Wang
- Hui Zhang (ORCID: https://orcid.org/0000-0002-0565-0411)
- Xuan Li (ORCID: https://orcid.org/0000-0002-2988-946X)
- Xiangli Yang (ORCID: https://orcid.org/0000-0001-8152-1833)
- Wenju Niu
- Xin Duan
- Zehui Li
- Qian Liang
- Guoqiang Yang
Institutions
- Shanxi Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
- Shanxi Academy of Medical Sciences (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2026-09-28
- DOI
- https://doi.org/10.1002/cns.71171
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00